CHESTPress ReleasesWorld Lung Day 2022

On World Lung Day, the Forum of International Respiratory Societies calls for action to tackle global inequity in respiratory health

September 23, 2022

Glenview, IL -  On World Lung Day, September 25, 2022, the Forum of International Respiratory Societies (FIRS), of which the American College of Chest Physicians (CHEST) is a founding member, calls on governments worldwide to address stark global inequalities in respiratory health.

The COVID-19 pandemic may have subsided, but its impact highlights a global lung health crisis that has not gone away.

Respiratory illnesses affect people in all countries, but disproportionally in low- and middle-income countries (LMICs) where resources for research, prevention and management are scarce. To address such inequity, we must look beyond medical care to the social and environmental determinants of health, such as tobacco use, air pollution, climate change and poverty.

Five respiratory diseases are the most common causes of illness and death worldwide—COPD, asthma, acute respiratory tract infection or pneumonia, TB and lung cancer.

The FIRS Global Impact of Respiratory Disease report shows the immense burden of these lung diseases:

An estimated 200 million people have COPD, of which about 3.2 million die each year, making it the third leading cause of death worldwide.

Asthma is one of the most common noncommunicable diseases globally, affecting 262 million people.

With more than 2.2 million new cases of lung cancer in 2020 and 1.8 million deaths, globally, lung cancer is responsible for 1 in 4 cancer deaths.

Lower respiratory tract infection or pneumonia is a leading cause of mortality, accounting for more than 2.4 million deaths every year, particularly among those in LMICs. COVID-19 has dramatically increased deaths from pneumonia globally.

In children under 5 years of age, pneumonia is the leading single cause of death outside the neonatal period.

TB is a major burden, with the World Health Organization’s annual global report finding that TB deaths have risen for the first time in more than a decade due to the COVID-19 pandemic.

FIRS asks that governments, health care workers and researchers focus on three key issues to help reduce respiratory health inequalities:

The global burden of the major respiratory diseases and the impact of COVID-19
The importance of early detection and screening
Reducing inequalities in screening, diagnosis, prevention and treatment of lung conditions

“The theme for this World Lung Day is Lung Health for All. That’s why we are calling on governments worldwide to work together to build equitable capacity, infrastructure and resources,” said FIRS President, Professor Heather Zar. “COVID has highlighted global inequities in access to effective strategies for respiratory health. We have very effective interventions to prevent and treat respiratory diseases, but these are unavailable or unaffordable in many parts of the world. Reducing inequality requires an integrated approach which incorporates social, environmental, economic and medical initiatives. We have effective interventions—but we must use these more equitably.”

About the Forum of International Respiratory Societies
The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world's leading international respiratory societies working together to improve lung health globally. The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

FIRS comprises the American College of Chest Physicians (CHEST), American Thoracic Society (ATS), the Asian Pacific Society of Respirology (APSR), Asociación Latinoamericana de Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Disease (The Union), Pan African Thoracic Society (PATS), the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

About the American College of Chest Physicians
The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.